| FWGIX | TQGIX | FWGIX / TQGIX | |
| Total Expense Ratio | 0.41 | 0.58 | 71% |
| Annual Report Gross Expense Ratio | 0.41 | 1.30 | 32% |
| Fund Existence | 9 years | 10 years | - |
| Gain YTD | 22.415 | 20.682 | 108% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 500000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 142B | 129M | 110,078% |
| Annual Yield % from dividends | 1.64 | 1.16 | 141% |
| Returns for 1 year | 13.02 | 13.56 | 96% |
| Returns for 3 years | 50.97 | 36.97 | 138% |
| Returns for 5 years | 43.24 | 44.86 | 96% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PEPSX | 34.48 | N/A | N/A |
| Principal Glb Emerging Markets R5 | |||
| TGVVX | 66.04 | N/A | N/A |
| Touchstone Dynamic Large Cap Growth I | |||
| WSCRX | 37.44 | N/A | N/A |
| Allspring Small Company Growth R6 | |||
| PHLQX | 52.77 | N/A | N/A |
| PGIM Jennison Health Sciences R6 | |||
| EEMHX | 10.14 | N/A | N/A |
| MFS Emerging Markets Equity Research R6 | |||